Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020

Seyed Ghaderian; AmirAbas Sadrian; Homeira Rashidi; Alireza Sedaghat

doi:10.5114/fmpcr.2022.120853

eISSN: 2449-8580
ISSN: 1734-3402

Family Medicine & Primary Care Review

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

4/2022
vol. 24

Send email

Copy url:

Original paper

Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020

Seyed Bahman Ghaderian

¹

,

AmirAbas Sadrian

²

,

Homeira Rashidi

¹

,

Alireza Sedaghat

²

Department of Internal Medicine, School of Medicine, Diabetes Research Centre, Health Research Institute, Ahwaz Jundishapur University of Medical Sciences, Ahwaz, Iran

Department of Internal Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahwaz, Iran

Family Medicine & Primary Care Review 2022; 24(4): 317–321

DOI: https://doi.org/10.5114/fmpcr.2022.120853

Online publish date: 2022/12/21

Article file

- 04 FM&PCR 4 22 - O - Ghaderian - Comparison - 1097.pdf [0.41 MB]

Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Ghaderian SB, Sadrian A, Rashidi H, Sedaghat A. Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020. Family Medicine & Primary Care Review. 2022;24(4):317-321. doi:10.5114/fmpcr.2022.120853.

APA

Ghaderian, S. B., Sadrian, A., Rashidi, H.,  & Sedaghat, A. (2022). Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020. Family Medicine & Primary Care Review, 24(4), 317-321. https://doi.org/10.5114/fmpcr.2022.120853

Chicago

Ghaderian, Seyed B, AmirAbas Sadrian, Homeira Rashidi,  and Alireza Sedaghat. 2022. "Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020". Family Medicine & Primary Care Review 24 (4): 317-321. doi:10.5114/fmpcr.2022.120853.

Harvard

Ghaderian, S., Sadrian, A., Rashidi, H.,  and Sedaghat, A. (2022). Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020. Family Medicine & Primary Care Review, 24(4), pp.317-321. https://doi.org/10.5114/fmpcr.2022.120853

MLA

Ghaderian, Seyed et al. "Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020." Family Medicine & Primary Care Review, vol. 24, no. 4, 2022, pp. 317-321. doi:10.5114/fmpcr.2022.120853.

Vancouver

Ghaderian S, Sadrian A, Rashidi H, Sedaghat A. Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020. Family Medicine & Primary Care Review. 2022;24(4):317-321. doi:10.5114/fmpcr.2022.120853.

PlumX metrics:

1. Grzegory A, Pomorski L. Perioperative calcium and vitamin D supplementation in patients undergoing thyroidectomy – literature review. Pol Przegl Chir 2018; 90(4): 46–50.

2. Genser L. Randomized controlled trial of alfacalcidol supplementation for the reduction of hypocalcemia after total thyroidectomy. Am J Surg 2014; 207(1): 39–45.

3. Bandeira LC, Rubin MR, Cusano NE, et al. Vitamin D and Hypoparathyroidism. Vitamin D in Clinical Medicine. In: Giustina A, Bilezikian JP, eds. Vitamin D in Clinical Medicine. Front Horm Res Basel, Karger, 2018; 50: 114–124, doi: 10.1159/000486075.

4. Al-Azem H, Khan AA. Hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 2012; 26: 517–522.

5. Huguet I, Munoz M, Cortes M, et al. Postoperative thyroid hypocalcemia diagnosis and management protocol. Rev Osteoporos Metab Miner 2020; 12(2): 71–76, doi: 10.4321/S1889-836X2020000200006.

6. Pepe J, Colangelo L, Biamonte F, et al. Diagnosis and management of hypocalcemia. Endocrine 2020; 69(3): 485–495.

7. Shoback DM, Bilezikian JP, Costa AG, et al. Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab 2016; 101: 2300–2312.

8. Bilezikian JP, Brandi ML, Cusano NE, et al. Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab 2016; 101(6): 2313–2324, doi: 10.1210/jc.2015-3910.

9. Streeten EA, Mohtasebi Y, Konig M, et al. Hypoparathyroidism: less severe hypocalcemia with treatment with vitamin D2 compared with calcitriol. J Clin Endocrinol Metab 2017; 102(5): 1505–1510, doi: 10.1210/jc.2016-3712.

10. Clarke BL, Vokes TJ, Bilezikian JP, et al. Effects of parathyroid hormone [rhPTH(1–84)] on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE Phase 3 Study. Endocrine 2017; 55: 273–282.

11. Ebeling PR, Adler RA, Jones G, et al. Management of endocrine disease: therapeutics of vitamin D. Euro J Endocrinol 2018; 179(5): R239–R259.

12. Underbjerg L, Sikjaer T, Mosekilde L, et al. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 2013; 28(11): 2277–2285.

13. Di Maio S, Soliman AT, De Sanctis V, et al. Current treatment of hypoparathyroidism: theory versus reality waiting guidelines for children and adolescents. Acta Biomed 2018; 89(1): 122–131, doi: 10.23750/abm.v89i1.7118.

14. Bringhurst FR, Demay MB, Kronenberg HM, et al. In: Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 13th edition. Philadelphia: Elsevier; 2016: 1277–1294.

15. Lowe H, Cusano NE, Binkley N, et al. Vitamin D toxicity due to a commonly available “over the counter” remedy from the Dominican Republic. J Clin Endocrinol Metab 2011; 96: 291–295.

16. Choe JH, Kim WW, Lee SK, et al. Comparison of calcitriol versus cholecalciferol therapy in addition to oral calcium after total thyroidectomy with central neck lymph node dissection: a prospective randomized study. Head Neck 2011; 33(9): 1265–1271, doi: 10.1002/hed.21619.

17. Bollerslev J, Rejnmark L, Marcocci C, et al. European Society of Endocrinology. European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 2015; 173(2): G1–G20.

18. Lam WY, Fresco P. Medication Adherence Measures: An Overview. Bio Med Res Int 2015; 2015: 217047.

19. Ravikumar K, Sadacharan D, Muthukumar S, et al. Prospective study on role of supplemental oral calcium and Vitamin D in prevention of postthyroidectomy hypocalcemia. Indian J Endocrinol Metab 2017; 21(4): 498, doi: 10.4103/ijem.IJEM_402_16.

20. Xing T, Hu Y, Wang B, et al. Role of oral calcium supplementation alone or with vitamin D in preventing post-thyroidectomy hypocalcaemia: a meta-analysis. Medicine (Baltimore) 2019; 98(8): e14455.

21. Alhefdhi A, Mazeh H, Chen H. Role of postoperative vitamin D and/or calcium routine supplementation in preventing hypocalcemia after thyroidectomy: a systematic review and meta-analysis. Oncologist 2013; 18(5): 533–542.

22. Roh JL. Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection. Cancer 2009; 115(2): 251–258.

23. Schilling T, Ziegler R. Current therapy of hypoparathyroidism – a survey of German endocrinology centers. Exp Clin Endocrinol Diabetes 1997; 105(4): 237–241.

24. McLeod IK, Arciero C, Noordzij JP, et al. The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. Thyroid 2006; 16: 259–265.

25. Sasson AR, Pingpank JF, Wetherington RW, et al. Incidental parathyroidectomy during thyroid surgery does not cause transient symptomatic hypocalcemia. Arch Otolaryngol Head Neck Surg 2001; 127: 304–308.

Copyright: © 2022 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020

Seyed Bahman Ghaderian 1 , AmirAbas Sadrian 2 , Homeira Rashidi 1 , Alireza Sedaghat 2

Seyed Bahman Ghaderian

¹

,

AmirAbas Sadrian

²

,

Homeira Rashidi

¹

,

Alireza Sedaghat

²